Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

  • Peter Bramlage, Jochen Seufert, Katrin Pegelow
  • Vascular Health and Risk Management, November 2013, Taylor & Francis
  • DOI: 10.2147/vhrm.s54362

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Peter Bramlage